This website uses cookies to collect necessary user browsing behaviors so that we can provide you with a better browsing experience. For more information, Please review the privacy policy

Disabling cookies will make it impossible to use member-related functions

The member-related functions have been closed due to the deactivation of cookies. Should reactivate cookies?

  • About
    • Company Profile
    • Company Introduction
    • R&D
      • Core Technology
      • PTS: Functional Mechanism
      • R&D Center
      • Paper Publish
    • History
    • Our Team
    • Partnership
      • Partnerships – Human Indication
      • Partnerships – Animal Drugs
  • News
    • Academic Activities
  • Product
    • Para-Toluenesulfonamide (PTS)
      • PTS: Functional Mechanism
      • Product Features
      • Comparison with existing cancer treatments
    • Market Position
    • R&D
      • PTS100
      • PTS500
      • PTS02
      • GWA103
      • GWA106
  • Pipeline
  • Clinical Trials
    • Product progress
  • Business Partnership
    • Partnerships – Human Indication
    • Partnerships – Animal Drugs
  • Investor zone
    • Important news
    • Financial area
      • Annual Report
      • Monthly Revenue
        • 2025
        • 2024
      • Consolidated Financial Reports
    • Shareholders area
    • Corporate Governance
  • Contact

下載產品DM

PTS Product Flyer Gongwin Biopharm Brochure
  • LINKEDIN
  • YOUTUBE
  • 中文
  • EN

INQUIRY

()
  • 中文
  • EN

下載產品DM

PTS Product Flyer Gongwin Biopharm Brochure

SCROLL DOWN

  • Home
  • Sitemap

Sitemap

  • About
    • Company Profile
    • Company Introduction
    • R&D
      • Core Technology
      • PTS: Functional Mechanism
      • R&D Center
      • Paper Publish
    • History
    • Our Team
    • Partnership
      • Partnerships – Human Indication
      • Partnerships – Animal Drugs
  • News
    • Academic Activities
  • Product
    • Para-Toluenesulfonamide (PTS)
      • PTS: Functional Mechanism
      • Product Features
      • Comparison with existing cancer treatments
    • Market Position
    • R&D
      • PTS100
      • PTS500
      • PTS02
      • GWA103
      • GWA106
  • Pipeline
    • Clinical Trials
      • Product progress
    • Business Partnership
      • Partnerships – Human Indication
      • Partnerships – Animal Drugs
    • Investor zone
      • Important news
      • Financial area
        • Annual Report
        • Monthly Revenue
          • 2025
          • 2024
        • Consolidated Financial Reports
      • Shareholders area
      • Corporate Governance
    • Contact

    TOP

    Please enter a product name
    • LINKEDIN
    • YOUTUBE
    Gongwin Biopharm Co., Ltd.
    TEL +886-2-2503-5282
    MAIL info@gongwinbiopharm.com
    ADDRESS 3F, No. 80, Sec. 1, Jianguo N. Rd., Zhongshan Dist., Taipei City 10491, Taiwan
    • LINKEDIN
    • YOUTUBE
    © 2026 Gongwin Biopharm Co., Ltd. All rights reserved. Designed By  Winho
    Privacy policy  |  Sitemap